Shares of CHF Solutions Inc (NASDAQ:CHFS) have received a consensus broker rating score of 1.00 (Strong Buy) from the two brokers that cover the company, Zacks Investment Research reports. Two equities research analysts have rated the stock with a strong buy recommendation.
Brokerages have set a 12-month consensus price target of $3.15 for the company and are forecasting that the company will post ($0.59) EPS for the current quarter, according to Zacks. Zacks has also assigned CHF Solutions an industry rank of 79 out of 255 based on the ratings given to related companies.
Several brokerages have weighed in on CHFS. Zacks Investment Research raised CHF Solutions from a “hold” rating to a “buy” rating and set a $1.25 price objective for the company in a report on Tuesday. Dawson James began coverage on CHF Solutions in a report on Tuesday, August 28th. They set a “buy” rating and a $3.30 price objective for the company. Finally, ValuEngine raised CHF Solutions from a “hold” rating to a “buy” rating in a report on Monday, July 2nd.
An institutional investor recently bought a new position in CHF Solutions stock. Perkins Capital Management Inc. acquired a new stake in shares of CHF Solutions Inc (NASDAQ:CHFS) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 58,962 shares of the company’s stock, valued at approximately $108,000. Perkins Capital Management Inc. owned 0.88% of CHF Solutions at the end of the most recent quarter. 20.58% of the stock is currently owned by institutional investors and hedge funds.
CHFS stock opened at $1.20 on Thursday. The company has a market capitalization of $8.35 million, a PE ratio of -0.03 and a beta of 2.33. CHF Solutions has a 12-month low of $0.93 and a 12-month high of $24.45.
CHF Solutions (NASDAQ:CHFS) last released its earnings results on Tuesday, August 7th. The company reported ($0.93) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.92) by ($0.01). CHF Solutions had a negative net margin of 471.94% and a negative return on equity of 166.88%. The business had revenue of $1.10 million during the quarter. On average, analysts anticipate that CHF Solutions will post -2.9 EPS for the current year.
CHF Solutions Company Profile
CHF Solutions, Inc, an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. The company focuses on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.
Recommended Story: Understanding Analyst Recommendations
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CHF Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CHF Solutions and related companies with MarketBeat.com's FREE daily email newsletter.